Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - | -347.04% |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn | 1,378.45% |
| 10 | Zentalis Pharmaceuticals | 315.84 Mn | 315.84 Mn | - | 5.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53% |
| Dec 31, 2025 | -1,684,442.92% |
| Sep 30, 2025 | 17.65% |
| Jun 30, 2025 | 38.29% |
| Mar 31, 2025 | -106.79% |
| Dec 31, 2024 | 98.10% |
| Sep 30, 2024 | -200.90% |
| Jun 30, 2024 | 30.99% |
| Mar 31, 2024 | 85.72% |
| Sep 30, 2023 | -25.74% |
| Jun 30, 2023 | 84.11% |
| Mar 31, 2023 | 69.16% |
| Sep 30, 2022 | 98.95% |
| Jun 30, 2022 | 80.17% |
| Mar 31, 2022 | 72.20% |
| Sep 30, 2021 | -327.78% |
| Jun 30, 2021 | -313.44% |
| Mar 31, 2021 | -396.19% |
| Dec 31, 2020 | -37.39% |
| Mar 31, 2020 | 99.15% |